Stable 5, 10-methylene-tetrahydrofolate pharmaceutical compounds

Details for Australian Patent Application No. 2004248923 (hide)

Owner Merck Eprova AG

Inventors Moser, Rudolf; Ammann, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2004248923

PCT Pub. Number WO2004/112761

Priority 2003 1123/03 26.06.03 CH

Filing date 28 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 2 December 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/191 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2004/112761 Priority application(s): WO2004/112761

2 December 2010 Application Accepted

  Published as AU-B-2004248923

8 December 2011 Alteration of Name

  The name of the applicant has been altered to Merck & Cie

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004248926-Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a nonvolatile oily phase

2004248914-HIP/PAP polypeptide composition for use in liver regeneration and for the prevention of liver failure